← Back to Screener
ScreenerNewsCompareWatchlist
VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemesNewsCompareWatchlist
AnalyzeValuationTotal ReturnDCA CalculatorInsider Activity
  1. Home
  2. GELS
  3. P/E History
OverviewPriceRevenueEarningsP/ERatiosDividendTargets

GELS logoGelteq Limited Ordinary Shares (GELS) P/E Ratio History

Historical price-to-earnings valuation from 2026 to 2026

Current P/E
N/A
N/A
5Y Avg P/E
N/A
PE Percentile
N/A
PEG Ratio
N/A
N/A
TTM EPSN/A
Price$0.47
5Y PE RangeN/A
Earnings YieldN/A

Loading P/E history...

GELS Valuation Context

How does the current P/E compare to historical and market benchmarks?

vs. 5Y Average
N/AvsN/A
N/A
vs. Healthcare
N/Avs22.3
N/A
vs. S&P 500
N/Avs25.1
N/A
PEG Analysis
N/A
P/E ÷ EPS Growth
Based on 100% EPS growth (1Y)

P/E Ratio Analysis

For a comprehensive intrinsic value estimate using discounted cash flow analysis, see our GELS DCF Valuation Calculator →

Note: P/E ratio is just one valuation metric. It does not account for balance sheet strength, cash flow quality, or growth sustainability. Always conduct comprehensive due diligence before making investment decisions.

GELS P/E vs Peers

P/E ratio compared to closely matched public peers

CompanyMarket CapP/E RatioPEG RatioEPS Growth (1Y)
PCRX logoPCRXPacira BioSciences, Inc.
$930M147.8-+107%
PAHC logoPAHCPhibro Animal Health Corporation
$2B36.3Lowest4.85Best+1883%Best
AMRX logoAMRXAmneal Pharmaceuticals, Inc.
$4B62.4-+158%
HIMS logoHIMSHims & Hers Health, Inc.
$7B50.3--4%

Peers sorted by market capitalization. P/E below peers may indicate undervaluation or lower growth expectations. Consider PEG ratio for growth-adjusted comparison.

See GELS's True Return

Price is only half the story. See total return with reinvested dividends.

Launch Calculator

Is GELS Undervalued?

DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.

View Valuation

Compare GELS vs DBVT

Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..

Start Comparison

GELS — Frequently Asked Questions

Quick answers to the most common questions about buying GELS stock.

Is GELS stock overvalued or undervalued?

GELS current P/E: N/A. 5-year average P/E: N/A. Percentile: N/A.

How does GELS's valuation compare to peers?

Gelteq Limited Ordinary Shares P/E of N/A compares to sector median of 22.3x. Sector comparison provides relative valuation context.

What is GELS's PEG ratio?

GELS PEG ratio is N/A. Above 2.0 indicates premium valuation relative to growth rate. Historical P/E data spans 2026-2026.

VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Patterns find ideas. Fundamentals build conviction.

Data updated daily

Quick Links

  • Home
  • Screener
  • Themes
  • Market Valuation
  • Valuation
  • Compare
  • Total Return
  • DCA Calculator
  • News
  • Insights
  • Methodology
  • How It Works
  • Profile

Popular Screens

  • VCP Hot
  • VCP Warm
  • Value Screens
  • Growth Screens
  • Momentum Screens
  • Technical Screens
  • Quality Screens

Community

  • Follow @VCPScanner on X

Get weekly stock ideas — free

© 2026 VCP Scanner. All rights reserved.
About·Privacy Policy·Terms of Service
Not financial advice. Do your own research.

GELS P/E Ratio History

P/E ratio calculated as closing price divided by trailing 12-month diluted EPS at each quarter end.